HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Clobetasol Propionate

HCID 32798
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
25122-46-7
Standard SMILES
CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
InChIKey
CBGUOGMQLZIXBE-XGQKBEPLSA-N
Molecular formula
C25H32ClFO5
Average molar mass
467 g/mol
Monoisotopic mass
466.19223

Overview

Clobetasol Propionate can cause developmental toxicity and female reproductive toxicity according to state or federal government labeling requirements.

Names & identifiers

Preferred name
Clobetasol Propionate
IUPAC
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
English name
Clobetasol propionate
Molecular formula
C25H32ClFO5
Molecular weight
466.97

Names & synonyms

CLOBETASOL PROPIONATE25122-46-7Clobetasol 17-propionateClobexDermovateTemovateEmbelineCormaxOluxEmbeline ETemovate EOlux-E
Show more names
CLOBETASOLE PROPIONATECLOBETASOL-17-PROPIONATE17-propionateClobetazole propionate21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione 17-propionate
ImpoyzPsorexCCI 4725GR 2/925clobetasol 17-propanoateOlux EClareluxDovate

Database identifiers

CAS
25122-46-7
PubChem CID
32798
DTXSID
DTXSID6045907
ChEMBL
CHEMBL1159650
ChEBI
CHEBI:31414
UNII
779619577M
EC Number
246-634-3
Nikkaji
J21.005F

Properties

Computed structural properties

XLogP
3.8
Topological polar surface area
80.7 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
5
Heavy atoms
32
Formal charge
0
Complexity
929

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations

Pharmaceuticals -> Listed in ZINC15

LogP3.18
Human Drugs · 3 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section205.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
195.5 · 195.5-1970C
alpha
103.8 ° · D +103.8° (c = 1.04 in dioxane)
Boiling point
569 · 569.0±50.0 °C(Predicted)
Density
1.1653 · 1.1653 (estimate)
storage temp.
2 · Keep in dark place,Sealed in dry,2-8°C
solubility
Practically insoluble in water, freely soluble in acetone, sparingly soluble in ethanol (96 per cent).
pka
12.88 · 12.88±0.70(Predicted)
form
Solid
color
White to off-white
Major Application
forensics and toxicologyveterinary
InChIKey
CBGUOGMQLZIXBE-XGQKBEPLSA-N
SMILES
O([C@@]1([C@H](C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C)C(=O)CCl)C(=O)CC |&1:1,2,4,6,16,18,20,23,r|
CAS DataBase Reference
25122 · 25122-46-7(CAS DataBase Reference)
FDA UNII
779619577 M · 779619577M
Proposition 65 List
Clobetasol Propionate
NCI Drug Dictionary
clobetasol propionate
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
360 Df-H373-H413 · H360Df-H373-H413
Precautionary statements
201 · P201-P273-P308+P313
target organs
Adrenal gland,Immune system
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xi,T
Risk Statements
36 · 36/37/38-62-53-48/20/21-61
Safety Statements
26 · 26-36-45-36/37-53
WGK Germany
2 · 2
RTECS
3725000 · TU3725000
HS Code
29372290 · 29372290
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 Repr · Aquatic Chronic 4Repr. 1BSTOT RE 2

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H315 (34.1%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P260, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 91 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Hazard Traits - Developmental Toxicity; Reproductive Toxicity

Clobetasol propionate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11.beta.,16.beta.)-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (34.1%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
2
rtecs
TU3725000
hs_code
29372290
risk_code
36/37/38-62-53-48/20/21-61
Signal word
Danger
Symbol(GHS)
GHS08
hazard_code
Xi,T
safety_code
26-36-45-36/37-53
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
target organs
Adrenal gland,Immune system
Hazard statements
H360Df-H373-H413
Hazard Classifications
Aquatic Chronic 4Repr. 1BSTOT RE 2
Precautionary statements
P201-P273-P308+P313

Chemistry & industry

Pharmacology

Protein BindingData regarding the protein binding of clobetasol propionate are not readily available. Corticosteroids are generally bound to corticosteroid binding globulin and serum albumin in plasma.
Pharmacodynamics · 1 item

Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals. Clobetasol propionate is generally applied twice daily so the duration of action is long. Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces. Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.

Mechanism of Action · 1 item

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive. High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.

Biological Half-LifeData regarding the half life of clobetasol propionate are not readily available.
Metabolism/Metabolites · 1 item

The metabolism of clobetasol propionate is not well studied but it does induce metabolic enzymes, even when delivered topically. The metabolism of clobetasol propionate is predicted to follow similar metabolic pathways to other corticosteroids including the addition of oxygen, hydrogen, glucuronides, and sulfates to form water soluble metabolites.

FDA Pharmacological Classification · 6 items

CLOBETASOL PROPIONATE

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

CLOBETASOL PROPIONATE CREAM USP, 0.05%

Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]

CLOBETASOL PROPIONATE OINTMENT USP, 0.05%

Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]

MeSH Pharmacological Classification · 2 items

Substances that reduce or suppress INFLAMMATION.

A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.

Absorption, Distribution and Excretion · 4 items

Twice daily application of clobetasol foam leads to a Cmax of 59±36pg/mL with a Tmax of 5 hours. Clobetasol cream showed an increase in clobetasol concentrations from 50.7±96.0pg/mL to 56.3±104.7pg/mL.

Corticosteroids are eliminated predominantly in the urine.

Data regarding the volume of distribution of clobetasole propionate are not readily available.

Data regarding the clearance of clobetasol propionate are not readily available.

Uses & manufacturing

Use ClassificationPharmaceuticals
Applications · 3 items

UsesClobetasol-17-propionate is a topical corticosteroid belonging to the group-D (hydrocortisone-q-butyrate) type of steroids.

UsesFor short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.

UsesTopical corticosteroid. Glucocorticoid; anti-inflammatory. Clobetasol propionate (Cormax, Temovate, Embeline, Olux) is one of the most potent of the currently available agents and is indicated for short-term treatment of inflammatory or hyperplastic disorders. It is a synthetic fluorinated corticosteroid. It may cause a more rapid or prolonged response than other topical corticosteroids. It is recommended that clobetasol have a maximum application of 60 g/week for no longer than 14 days without occlusion and that it should not be used in children below age 12.

Upstream & downstream products

Upstream raw materials

Propionic anhydrideLithium chloride

Additional notes

DefinitionChEBI: The 17-O-propionate ester of clobetasol. A potent corticosteroid, it is used to treat various skin disorders, including exzema and psoriasis.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes